We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.2M
AUM Growth
-$16M
Cap. Flow
-$12.8M
Cap. Flow %
-13.02%
Top 10 Hldgs %
57.17%
Holding
92
New
14
Increased
16
Reduced
24
Closed
27

Top Buys

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$1.78M
2
BKNG icon
Booking.com
BKNG
+$1.68M
3
RTK
Rentech, Inc.
RTK
+$1.66M
4
CSII
Cardiovascular Systems, Inc.
CSII
+$1.33M
5
CDZI icon
Cadiz
CDZI
+$1.16M

Top Sells

Rank Stock Value
1
SYT
Syngenta Ag
SYT
+$6.05M
2
LSAK icon
Lesaka Technologies
LSAK
+$3.8M
3
TLPH icon
Talphera
TLPH
+$2.99M
4
CUTR
Cutera, Inc.
CUTR
+$1.56M
5
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
+$1.42M

Sector Composition

Rank Sector Weight
1 Healthcare 44.84%
2 Technology 18.47%
3 Financials 8.1%
4 Communication Services 7.26%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLOG
51
DELISTED
GASLOG LTD
GLOG
$144K 0.15%
4,500
-2,600
-37% -$68.1K
RKUS
52
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$137K 0.14%
+11,500
New +$122K
CVGW
53
DELISTED
Calavo Growers
CVGW
$125K 0.13%
3,700
-100
-3% -$3.27K
LMNR icon
54
Limoneira
LMNR
$246M
$121K 0.12%
5,500
+3,800
+224% +$85.4K
AWK icon
55
American Water Works
AWK
$27.2B
$119K 0.12%
2,400
-1,200
-33% -$56.4K
PNR icon
56
Pentair
PNR
$9.91B
$108K 0.11%
2,234
-1,191
-35% -$60.6K
AGRO icon
57
Adecoagro
AGRO
$1.54B
$107K 0.11%
11,300
-7,700
-41% -$70K
CP icon
58
Canadian Pacific Kansas City
CP
$82.5B
$104K 0.11%
2,875
-1,125
-28% -$36.9K
LNG icon
59
Cheniere Energy
LNG
$58B
$100K 0.1%
1,400
– –
SLB icon
60
SLB Ltd
SLB
$81.6B
$83K 0.08%
700
-1,400
-67% -$144K
SMSI icon
61
Smith Micro Software
SMSI
$16.5M
$83K 0.08%
500
-283
-36% -$56.2K
XYL icon
62
Xylem
XYL
$26.3B
$63K 0.06%
1,600
-800
-33% -$29.9K
PDCE
63
DELISTED
PDC Energy, Inc.
PDCE
$63K 0.06%
+1,000
New +$62.8K
RNET
64
DELISTED
RigNet, Inc.
RNET
$54K 0.06%
+1,000
New +$50.1K
ALT icon
65
Altimmune
ALT
$630M
– –
-608
Closed -$335K
EGHT icon
66
8x8 Inc
EGHT
$290M
– –
-40,300
Closed -$436K
EW icon
67
Edwards Lifesciences
EW
$51.8B
– –
-42,000
Closed -$519K
GERN icon
68
Geron
GERN
$983M
– –
-149,072
Closed -$295K
LNN icon
69
Lindsay Corp
LNN
$1.16B
– –
-1,700
Closed -$150K
LSAK icon
70
Lesaka Technologies
LSAK
$391M
– –
-381,490
Closed -$3.8M
MDGL icon
71
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-734
Closed -$111K
NGS icon
72
Natural Gas Services Group
NGS
$457M
– –
-7,100
Closed -$214K
NKTR icon
73
Nektar Therapeutics
NKTR
$2.55B
– –
-4,013
Closed -$728K
NSPR icon
74
InspireMD
NSPR
$41.6M
– –
0
– -$511K
QLYS icon
75
Qualys
QLYS
$6.52B
– –
-10,738
Closed -$275K
1 2
3
4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Sophrosyne Capital held 92 positions worth $98.2M, down 14% from $114M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sophrosyne Capital withdrew a net $12.8M in Q2 2014, closing 27 positions and reducing 24 holdings. Its most notable exit was Syngenta Ag, an estimated $6.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Financials.

Against the trend, Sophrosyne Capital opened a new position in DURECT Corp worth $2.31M.

  • Sophrosyne Capital's largest Q2 2014 buy was DURECT Corp: 126,902 shares worth $2.31M.
  • Sophrosyne Capital added most to Rentech, Inc. in Q2 2014, an estimated $1.66M increase.
  • Sophrosyne Capital's biggest Q2 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $1.16M.
  • Sophrosyne Capital fully exited Syngenta Ag in Q2 2014, selling an estimated $6.05M.
  • Sophrosyne Capital's ten largest holdings make up 57% of its $98.2M portfolio in Q2 2014.
  • Sophrosyne Capital opened 14 new positions and closed 27 in Q2 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $98.2M.

Based on Sophrosyne Capital's 13F filing for Q2 2014, filed 14 Aug 2014.